Stroke (ischemic) - management

Ischemic stroke management focuses on rapid diagnosis, restoring blood flow to the affected brain area via thrombolysis (tPA) or mechanical thrombectomy, and preventing complications. Secondary prevention strategies and comprehensive rehabilitation are essential for reducing recurrence risk and maximizing functional recovery.

Note 1: Initial Assessment and Stabilization

The immediate management of suspected ischemic stroke revolves around rapid assessment and stabilization. The acronym FAST (Face, Arms, Speech, Time) is a widely used tool for quick recognition of stroke symptoms by both the public and medical professionals. Upon arrival at the hospital, the priority is to confirm the diagnosis and rule out other conditions that may mimic stroke, such as hypoglycemia, seizures, or brain tumors. A non-contrast CT scan of the head is crucial as the first-line imaging modality to differentiate between ischemic and hemorrhagic stroke. Vital signs, including blood pressure, heart rate, respiratory rate, and oxygen saturation, must be monitored and stabilized. Hypertension is common after acute stroke, but aggressive lowering of blood pressure should be avoided initially unless there are specific indications like aortic dissection or malignant hypertension. The National Institutes of Health Stroke Scale (NIHSS) is a standardized neurological examination tool used to quantify the severity of the stroke and monitor changes over time. Accurate and timely assessment is paramount, as the window of opportunity for effective interventions is limited.

Note 2: Thrombolysis with IV tPA (Alteplase)

Intravenous thrombolysis with tissue plasminogen activator (tPA), also known as alteplase, is the cornerstone of acute ischemic stroke treatment. tPA is a recombinant protein that converts plasminogen to plasmin, which degrades fibrin, the main component of blood clots. The primary goal is to dissolve the clot blocking the artery and restore blood flow to the ischemic brain tissue. However, tPA has strict inclusion and exclusion criteria. It must be administered within 4.5 hours of symptom onset, and patients must meet specific clinical and imaging criteria. Contraindications include active bleeding, recent surgery, a history of intracranial hemorrhage, and severe uncontrolled hypertension. The most significant risk associated with tPA is intracranial hemorrhage, which can lead to significant morbidity and mortality. Therefore, a careful risk-benefit assessment is crucial before administering tPA. After tPA administration, close monitoring of neurological status, blood pressure, and signs of bleeding is essential.

Note 3: Mechanical Thrombectomy

Mechanical thrombectomy is an endovascular procedure used to remove large vessel occlusions (LVOs) in the brain. LVOs typically affect the proximal portions of the major cerebral arteries, such as the middle cerebral artery (MCA) and internal carotid artery (ICA). This procedure involves inserting a catheter through an artery in the groin and guiding it to the blocked artery in the brain. A stent retriever or aspiration device is then used to grab or suck out the clot, restoring blood flow. Clinical trials have demonstrated that mechanical thrombectomy significantly improves outcomes in patients with LVOs, especially when performed within 6-24 hours of symptom onset in select patients who meet strict clinical and imaging criteria. The availability of mechanical thrombectomy centers varies geographically, emphasizing the importance of rapid triage and transfer of eligible patients to these specialized centers. Recent advancements in thrombectomy devices and techniques have further improved the success rates and reduced complications associated with this procedure.

Note 4: Blood Pressure Management

Blood pressure management in acute ischemic stroke is a nuanced and critical aspect of care. Initially, hypertension is common and may be a compensatory mechanism to maintain cerebral perfusion. Guidelines recommend against aggressive blood pressure lowering unless certain criteria are met. For patients eligible for tPA, blood pressure should be maintained below 185/110 mmHg before, during, and for 24 hours after tPA infusion. For patients not receiving tPA, permissive hypertension (up to 220/120 mmHg) may be tolerated in the acute phase. After the acute phase, blood pressure should be gradually reduced to prevent further stroke and cardiovascular events. The choice of antihypertensive medications should be tailored to the individual patient, considering factors such as co-morbidities and potential drug interactions. Frequent monitoring of blood pressure and neurological status is essential to detect any adverse effects of blood pressure management.

Note 5: Antiplatelet Therapy

Antiplatelet therapy is a crucial component of secondary stroke prevention. Aspirin is typically initiated within 24-48 hours after stroke onset in patients who are not receiving tPA. For patients who have received tPA, aspirin is usually delayed for 24 hours to reduce the risk of intracranial hemorrhage. In some cases, dual antiplatelet therapy with aspirin and clopidogrel may be considered for a short period (e.g., 21 days) in patients with high-risk transient ischemic attacks (TIAs) or minor strokes. Long-term antiplatelet therapy is recommended to reduce the risk of recurrent stroke. The choice of antiplatelet agent depends on individual patient factors, such as risk factors for bleeding, co-morbidities, and tolerance to the medication. Common misconceptions include the belief that antiplatelet therapy is a substitute for thrombolysis or thrombectomy in the acute phase.

Note 6: Supportive Care and Complication Management

Supportive care is essential in the management of acute ischemic stroke. This includes monitoring and managing potential complications such as pneumonia, urinary tract infections, deep vein thrombosis (DVT), and pressure ulcers. Early mobilization and rehabilitation are crucial to prevent complications and promote functional recovery. Dysphagia (difficulty swallowing) is common after stroke and can lead to aspiration pneumonia. Therefore, a swallowing assessment should be performed before oral intake is initiated. Nutritional support should be provided to ensure adequate caloric intake and prevent malnutrition. Bowel and bladder management is also important to prevent constipation and urinary retention. Psychological support is crucial to address the emotional and cognitive impact of stroke on patients and their families.

Note 7: Secondary Prevention Strategies

Secondary prevention aims to reduce the risk of recurrent stroke after an initial event. This involves addressing modifiable risk factors such as hypertension, hyperlipidemia, diabetes, smoking, and atrial fibrillation. Lifestyle modifications, including a healthy diet, regular exercise, and smoking cessation, are essential. Medications such as antihypertensives, statins, and anticoagulants may be prescribed based on individual risk factors and underlying conditions. Carotid endarterectomy or carotid artery stenting may be considered in patients with significant carotid artery stenosis. Patent foramen ovale (PFO) closure may be considered in select patients with cryptogenic stroke and a PFO. Adherence to secondary prevention strategies is crucial to reduce the risk of recurrent stroke and improve long-term outcomes.

Note 8: Rehabilitation and Recovery

Rehabilitation is a critical aspect of stroke management, aimed at maximizing functional recovery and improving quality of life. Rehabilitation should be initiated as early as possible, ideally within the first few days after stroke onset. A multidisciplinary team, including physical therapists, occupational therapists, speech therapists, and neuropsychologists, works together to develop individualized rehabilitation plans. Physical therapy focuses on improving motor function, balance, and mobility. Occupational therapy focuses on improving activities of daily living (ADLs) and upper extremity function. Speech therapy addresses communication and swallowing difficulties. Neuropsychological rehabilitation addresses cognitive deficits such as memory, attention, and executive function. The intensity and duration of rehabilitation should be tailored to the individual patient's needs and goals. Ongoing support and encouragement are essential to promote long-term recovery.

Note 9: Addressing Common Misconceptions

Several misconceptions surround stroke management. One common misconception is that stroke only affects the elderly. While the risk of stroke increases with age, it can occur at any age, including in children and young adults. Another misconception is that stroke is untreatable. While some stroke-related disabilities may be permanent, timely treatment with thrombolysis or thrombectomy can significantly improve outcomes and reduce long-term disability. A third misconception is that all strokes are the same. Strokes can vary widely in severity and location, leading to different symptoms and outcomes. Finally, some people believe that if symptoms improve quickly, it wasn't a stroke. TIAs (Transient Ischemic Attacks) can have similar symptoms, but can be a warning sign of a future, more serious stroke and should be evaluated immediately.

Note 10: Telemedicine in Stroke Care

Telemedicine has emerged as a valuable tool in improving access to acute stroke care, particularly in rural and underserved areas. Telestroke programs utilize video conferencing technology to connect stroke specialists with patients and healthcare providers in remote locations. This allows for real-time assessment of stroke symptoms, review of imaging studies, and consultation regarding treatment options, including thrombolysis. Telestroke can reduce door-to-needle times for tPA administration and increase the proportion of patients who receive appropriate acute stroke treatment. Furthermore, telemedicine can facilitate the transfer of eligible patients to specialized stroke centers for mechanical thrombectomy. The expansion of telestroke programs has the potential to significantly improve outcomes for stroke patients in areas with limited access to stroke expertise.

Note 11: Future Directions in Stroke Management

Research in stroke management is constantly evolving, with ongoing efforts to develop new and improved treatments. One promising area of research is the development of neuroprotective agents that can protect brain tissue from damage during and after a stroke. Other areas of investigation include new thrombolytic agents with improved safety profiles, advanced imaging techniques to better identify salvageable brain tissue, and innovative rehabilitation strategies to enhance functional recovery. Artificial intelligence (AI) and machine learning are also being explored to improve stroke diagnosis, treatment planning, and prediction of outcomes. Ultimately, the goal is to develop more effective and personalized approaches to stroke management that can improve outcomes and reduce the burden of this devastating condition.

Browse public study notes